PTPRC and Miyoshi myopathy: Here, we report a novel microfluidic approach, combining microfluidic size selection and CD45 depletion with tetrameric antibody complexes (TACs) for enrichment of MM cells in bone marrow samples (MF‐CD45‐TAC enrichment).